Dr. Dennis Salmon, professor and chief of hematology/oncology at UCLA and UCLA IUO physician-scientist, has been awarded the 2019 Lasker-DeBakey Clinical Medical Research Award for the groundbreaking development of breast cancer drug Herceptin (trastuzumab), a lifesaving therapy for women with HER2-positive breast cancer. The award, to be presented on Sept. 20, is widely regarded as America’s top biomedical research prize. UCLA Newsroom >
An international team of researchers led by Paul Boutros, PhD, have created a new way to accurately estimate how fast an individual cancer is evolving using open-source software, which makes big data sets easily accessible to the public. JCCC news release >
Dr. Brian Shuch, associate professor of urology and Dr. Sandy Liu, clinical instructor in medicine, hematology-oncology, present an overview of The UCLA Kidney Cancer Program that spans across multiple departments to bring the very best of UCLA to fight a challenging disease.
What You Should Know
As the number of COVID-19 cases are expected to grow in the coming months, more people will have to take extra measures to help protect themselves and reduce the transmission of the disease. This is particularly important for people with cancer.
Read more about precautions cancer patients need to take >
UCLA Health COVID-19 Coronavirus update >
Targeted Treatment of Metastatic Castration-Resistant Prostate Cancer
The purpose of this study is to see if the study drug, Trametinib, is safe and effective for the treatment of metastatic castration-resistant prostate cancer. View Clinical Trial >
UCLA researcher uses big data to help optimize cancer treatment. How can datasets help reveal new ways to treat cancer? UCLA Jonsson Cancer Center's Paul Boutros shares how his lab is working in collaboration with research centers around the world to use big data to help develop new ways to fight this disease.
Story on newsroom.ucla.edu >
